XTL Biopharmaceuticals Ltd. Sponsored ADR's market cap is currently $19.34M. The company's EPS TTM is $-0.136; its P/E ratio is ―; XTL Biopharmaceuticals Ltd. Sponsored ADR is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 0.00	$ -459.00K	$ 1.47M	$ 28.00K	$ 69.00K
Gross Profit	$ 0.00	$ -460.00K	$ 1.47M	$ 27.00K	$ 69.00K
Operating Income	$ -765.00K	$ -880.00K	$ -1.03M	$ -948.00K	$ -842.00K
EBITDA	$ -764.00K	$ -879.00K	$ -1.03M	$ -947.00K	$ 0.00
Net Income	$ -1.78K	$ -2.31M	$ 1.90M	$ -616.00K	$ -1.28M
Balance Sheet
Cash & Short-Term Investments	$ 2.01M	$ 3.72M	$ 6.13M	$ 6.04M	$ 6.73M
Total Assets	$ 2.43M	$ 4.19M	$ 6.62M	$ 6.50M	$ 7.21M
Total Debt	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Net Debt	$ -1.40M	$ -2.09M	$ -2.97M	$ -3.63M	$ -4.46M
Total Liabilities	$ 206.00K	$ 187.00K	$ 1.28M	$ 254.00K	$ 232.00K
Stockholders' Equity	$ 2.22M	$ 4.00M	$ 5.33M	$ 6.25M	$ 6.98M
Cash Flow
Free Cash Flow	$ -707.00K	$ -901.00K	$ -1.05M	$ -851.00K	$ -910.00K
Operating Cash Flow	$ -707.00K	$ -901.00K	$ -1.05M	$ -850.00K	$ -908.00K
Investing Cash Flow	$ 41.00K	$ 36.00K	$ 8.00K	$ 32.00K	$ 2.11M
Financing Cash Flow	$ 0.00	$ 0.00	$ 385.00K	$ 0.00	$ 0.00

Currency in USD

XTL Biopharmaceuticals Ltd. Sponsored ADR Earnings and Revenue History

Income Statement >

XTL Biopharmaceuticals Ltd. Sponsored ADR Debt to Assets

Balance Sheet >

XTL Biopharmaceuticals Ltd. Sponsored ADR Cash Flow

Cash Flow >

XTL Biopharmaceuticals Ltd. Sponsored ADR Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing